Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-upRichard A. Larson, H. Kantarjian, Andreas Hochhaus et al.|Leukemia|2012Cited by 440
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet StudyDaniela Cilloni, David Grimwade, Aline Renneville et al.|Journal of Clinical Oncology|2009Cited by 434
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)Elias Jabbour, Andreas Hochhaus, Jiří Mayer et al.|Blood|2013Cited by 391
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersFrancesca Bonifazi, Michele Baccarani, Antonio De Vivo et al.|Blood|2001Cited by 319